Literature DB >> 36279091

Jejunal Mesentery Preservation Reduces Leakage at Esophagojejunostomy After Minimally Invasive Total Gastrectomy for Gastric Cancer: a Propensity Score-Matched Cohort Study.

Naoshi Kubo1, Katsunobu Sakurai2, Yutaka Tamamori2, Tsuyoshi Hasegawa2, Shuhei Kushiyama2, Kenji Kuroda2, Akihiro Murata2,3, Shintaro Kodai3, Takafumi Nishii2, Akiko Tachimori2, Sadatoshi Shimizu2,3, Akishige Kanazawa3, Toru Inoue2, Kiyoshi Maeda2,4, Yukio Nishiguchi2.   

Abstract

PURPOSE: The mesentery of the jejunum (MJ) of the Roux limb is conventionally divided when Roux-en-Y reconstruction is performed after total gastrectomy for gastric cancer (GC). However, the impact of dividing or preserving the MJ on anastomotic leakage (AL) at the esophagojejunostomy (EJS) site after minimally invasive total gastrectomy for GC is unclear.
METHODS: This retrospective cohort study enrolled 226 patients with GC who underwent EJS after laparoscopic or robotic total gastrectomy, including preservation of the MJ (n = 87) and division of the MJ (n = 137). The prevalence of anastomotic complications at the EJS and short-term outcomes were compared between groups using propensity score (PS) matching.
RESULTS: After PS matching, 69 patients were selected for the preserving and dividing MJ groups. There were no significant intergroup differences in patient backgrounds, including oncological stage, body mass index, and gender ratio. After PS matching, overall and severe complications after surgery were compared between the preserving and dividing MJ groups (21.7% vs. 27.5%, p = 0.554 and 8.7% vs. 13.8%, p = 0.137, respectively). However, the rate of AL at the EJS was significantly lower in the preserving than that in the dividing MJ group (1.4% vs. 13.0%, p = 0.017). In addition, the median postoperative hospital stay was significantly shorter in the preserving than that in the dividing MJ group (13.0 days vs. 16.0 days, p = 0.005).
CONCLUSIONS: Preserving the MJ significantly reduced AL at the EJS after minimally invasive total gastrectomy for GC.
© 2022. The Society for Surgery of the Alimentary Tract.

Entities:  

Keywords:  Anastomotic leakage; Esophagojejunostomy; Gastric cancer; Jejunal mesentery; Total gastrectomy

Year:  2022        PMID: 36279091     DOI: 10.1007/s11605-022-05494-8

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.267


  28 in total

1.  A randomized controlled trial comparing open vs laparoscopy-assisted distal gastrectomy for the treatment of early gastric cancer: an interim report.

Authors:  Seigo Kitano; Norio Shiraishi; Kyuzo Fujii; Kazuhiro Yasuda; Masafumi Inomata; Yosuke Adachi
Journal:  Surgery       Date:  2002-01       Impact factor: 3.982

2.  Assessment of Robotic Versus Laparoscopic Distal Gastrectomy for Gastric Cancer: A Randomized Controlled Trial.

Authors:  Jun Lu; Chao-Hui Zheng; Bin-Bin Xu; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Qi-Yue Chen; Long-Long Cao; Mi Lin; Ru-Hong Tu; Ze-Ning Huang; Ju-Li Lin; Hua-Long Zheng; Chang-Ming Huang; Ping Li
Journal:  Ann Surg       Date:  2021-05-01       Impact factor: 12.969

3.  Decreased Morbidity of Laparoscopic Distal Gastrectomy Compared With Open Distal Gastrectomy for Stage I Gastric Cancer: Short-term Outcomes From a Multicenter Randomized Controlled Trial (KLASS-01).

Authors:  Wook Kim; Hyung-Ho Kim; Sang-Uk Han; Min-Chan Kim; Woo Jin Hyung; Seung Wan Ryu; Gyu Seok Cho; Chan Young Kim; Han-Kwang Yang; Do Joong Park; Kyo Young Song; Sang Il Lee; Seung Yub Ryu; Joo-Ho Lee; Hyuk-Joon Lee
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

4.  Short-term Outcomes of a Multicenter Randomized Controlled Trial Comparing Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy to Open Distal Gastrectomy for Locally Advanced Gastric Cancer (KLASS-02-RCT).

Authors:  Hyuk-Joon Lee; Woo Jin Hyung; Han-Kwang Yang; Sang Uk Han; Young-Kyu Park; Ji Yeong An; Wook Kim; Hyoung-Il Kim; Hyung-Ho Kim; Seung Wan Ryu; Hoon Hur; Seong-Ho Kong; Gyu Seok Cho; Jin-Jo Kim; Do Joong Park; Keun Won Ryu; Young Woo Kim; Jong Won Kim; Joo-Ho Lee; Min-Chan Kim
Journal:  Ann Surg       Date:  2019-12       Impact factor: 12.969

5.  Less Severe Intra-Abdominal Infections in Robotic Surgery for Gastric Cancer Compared with Conventional Laparoscopic Surgery: A Propensity Score-matched Analysis.

Authors:  Naoshi Kubo; Katsunobu Sakurai; Yutaka Tamamori; Yasuyuki Fukui; Kenji Kuroda; Naoki Aomatsu; Takafumi Nishii; Akiko Tachimori; Kiyoshi Maeda
Journal:  Ann Surg Oncol       Date:  2022-02-18       Impact factor: 5.344

6.  Short-term Outcomes of Robotic Gastrectomy vs Laparoscopic Gastrectomy for Patients With Gastric Cancer: A Randomized Clinical Trial.

Authors:  Toshiyasu Ojima; Masaki Nakamura; Keiji Hayata; Junya Kitadani; Masahiro Katsuda; Akihiro Takeuchi; Shinta Tominaga; Tomoki Nakai; Mikihito Nakamori; Masaki Ohi; Masato Kusunoki; Hiroki Yamaue
Journal:  JAMA Surg       Date:  2021-10-01       Impact factor: 16.681

7.  Morbidity and mortality from a propensity score-matched, prospective cohort study of laparoscopic versus open total gastrectomy for gastric cancer: data from a nationwide web-based database.

Authors:  Tsuyoshi Etoh; Michitaka Honda; Hiraku Kumamaru; Hiroaki Miyata; Kazuhiro Yoshida; Yasuhiro Kodera; Yoshihiro Kakeji; Masafumi Inomata; Hiroyuki Konno; Yasuyuki Seto; Seigo Kitano; Naoki Hiki
Journal:  Surg Endosc       Date:  2017-12-07       Impact factor: 4.584

8.  Laparoscopic approaches in the management of patients with early gastric carcinomas.

Authors:  S Kitano; K Shimoda; M Miyahara; N Shiraishi; T Bandoh; T Yoshida; K Shuto; M Kobayashi
Journal:  Surg Laparosc Endosc       Date:  1995-10

9.  Long-term Outcomes of Laparoscopic Versus Open Surgery for Clinical Stage II/III Gastric Cancer: A Multicenter Cohort Study in Japan (LOC-A Study).

Authors:  Takahiro Kinoshita; Ichiro Uyama; Masanori Terashima; Hirokazu Noshiro; Eishi Nagai; Kazutaka Obama; Yutaka Tamamori; Toshinaga Nabae; Michitaka Honda; Takayuki Abe
Journal:  Ann Surg       Date:  2019-05       Impact factor: 12.969

10.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.